Back to Top Skip to main content

2016 Meetings

February 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Oral Contraceptives
  • Antifungal Agents - Topical Laquers
  • Opthalmic Anti-Inflammatory/ Immunomodulatory Agents - Ophthalmic Immunomodulatory Agents
Tivorbex, Pazeo, Afrezza, Striverdi Respimat

Rexulti, Entresto -Solicitation cancelled
Adynovate, Alecensa, Coagadex, Cotellic, Durlaza, Dyanavel XR, Genvoya, Narcan nasal, Ninlaro, Seebri Neohaler, Strensiq, Tagrisso, Tresiba, Uptravi, Utibron Neohaler, Varubi, Veltassa, Vivlodex

May 11-12, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Oral Contraceptives - Emergency Contraceptives
  • Anticonvulsants
  • Antipsychotic Agents - Atypical
Entresto, Viberzi

Zecuity - Solicitation Cancelled
Adzenys XR-ODT, Belbuca, Enstilar, Idelvion, Kovaltry, Odefsey, Quillichew ER, Taltz, Vraylar, Xeljanx XR, Xuriden, Zepatier

August 10-11, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Acne Agents - Topical and Roseacea Agents
  • Migraine Agents - Triptans
  • Alcohol Deterrents - Narcotic Antagonists
N/A Afstyla, Briviact, Cabometyx, Aczone, Descovy, Epclusa, Ferriprox, Jentadueto XR, Nuplazid, Ocaliva, Orfadin, Sernivo, Onzetra Xsail, Zembrance SymTouch, Tolak, Ultravate, Venclexta, Xtampza ER

November 16-17, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Anticoagulants - Oral Anticoagulants
  • Antilipidemics-1 - PCSK9s
Spiriva Respimat
Bevespi Aeroshere, Byvalson, Emend, Gonitro, Invokamet XR, Otovel, Qbrelis, Relistor, Taytulla, Vonvendi, Xiidra, Yosprala, Zinbryta, Zurampic

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.